首页 > 最新文献

Tanaffos最新文献

英文 中文
Mortality Rate and Its Contributing Factors in Post-Surgical and Medical Patients with AKI Underwent CRRT. 术后和内科AKI患者行CRRT的死亡率及其影响因素
Q3 Medicine Pub Date : 2024-01-01
Fatemeh Yassari, Batoul Khoundabi, Farin Rashid Farokhi, Rajesh Chandra Mishra, Ahsina Jahan Lopa, Seyed MohammadReza Hashemian

Background: Acute kidney injury (AKI) requires continuous renal replacement therapy (CRRT), which is one of the most important problems in medical and surgical patients. Therefore, it is very important to identify the influencing factors to reduce the dimensions of the problem. This study was conducted to investigate the mortality rate in medical and surgical patients with AKI requiring CRRT treatment.

Materials and methods: In this observational study, which was conducted as a cross- sectional analytical study, 100 patients with AKI requiring CRRT treatment, including medical and surgical patients, were selected from 2018 to 2021 at Masih Daneshvari Hospital. The mortality rate was estimated. Also, the effective factors were investigated and compared between the dead and surviving patients.

Results: 85 cases (85%) of the patients died. Most underlying and demographic variables had no statistically significant difference between the dead and surviving patients (P>0.05). However, in the cases of primary calcium (P=0.001), primary leukocyte (P=0.037), bicarbonate during hospitalization (P=0.025), bicarbonate during AKI (P=0.028), magnesium during hospitalization (P=0.038), and magnesium at the end of CRRT (P=0.019), the differences were statistically significant.

Conclusion: In conclusion, mortality is observed in 5 out of 6 patients with acute kidney failure who need CRRT treatment, which is related to risk factors such as bicarbonate, magnesium, leukocyte, and calcium levels. Therefore, multifaceted planning is needed to reduce its dimensions to improve the prognosis of this group of patients.

背景:急性肾损伤(AKI)需要持续肾替代治疗(CRRT),这是内科和外科患者最重要的问题之一。因此,确定影响因素以减少问题的规模是非常重要的。本研究旨在调查需要CRRT治疗的内科和外科AKI患者的死亡率。材料和方法:在这项观察性研究中,作为一项横断面分析研究,选择了2018年至2021年在Masih Daneshvari医院(Masih Daneshvari Hospital)接受CRRT治疗的100例AKI患者,包括内科和外科患者。估计了死亡率。并对死亡和存活患者的影响因素进行了调查和比较。结果:85例(85%)患者死亡。大多数基础和人口统计学变量在死亡和存活患者之间无统计学差异(P < 0.05)。然而,在原发性钙(P=0.001)、原发性白细胞(P=0.037)、住院期间碳酸氢盐(P=0.025)、AKI期间碳酸氢盐(P=0.028)、住院期间镁(P=0.038)和CRRT结束时镁(P=0.019)的情况下,差异有统计学意义。结论:综上所述,6例需要CRRT治疗的急性肾衰竭患者中有5例出现死亡率,这与碳酸氢盐、镁、白细胞、钙水平等危险因素有关。因此,需要多方面的规划,减少其维度,以改善该组患者的预后。
{"title":"Mortality Rate and Its Contributing Factors in Post-Surgical and Medical Patients with AKI Underwent CRRT.","authors":"Fatemeh Yassari, Batoul Khoundabi, Farin Rashid Farokhi, Rajesh Chandra Mishra, Ahsina Jahan Lopa, Seyed MohammadReza Hashemian","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Acute kidney injury (AKI) requires continuous renal replacement therapy (CRRT), which is one of the most important problems in medical and surgical patients. Therefore, it is very important to identify the influencing factors to reduce the dimensions of the problem. This study was conducted to investigate the mortality rate in medical and surgical patients with AKI requiring CRRT treatment.</p><p><strong>Materials and methods: </strong>In this observational study, which was conducted as a cross- sectional analytical study, 100 patients with AKI requiring CRRT treatment, including medical and surgical patients, were selected from 2018 to 2021 at Masih Daneshvari Hospital. The mortality rate was estimated. Also, the effective factors were investigated and compared between the dead and surviving patients.</p><p><strong>Results: </strong>85 cases (85%) of the patients died. Most underlying and demographic variables had no statistically significant difference between the dead and surviving patients (P>0.05). However, in the cases of primary calcium (P=0.001), primary leukocyte (P=0.037), bicarbonate during hospitalization (P=0.025), bicarbonate during AKI (P=0.028), magnesium during hospitalization (P=0.038), and magnesium at the end of CRRT (P=0.019), the differences were statistically significant.</p><p><strong>Conclusion: </strong>In conclusion, mortality is observed in 5 out of 6 patients with acute kidney failure who need CRRT treatment, which is related to risk factors such as bicarbonate, magnesium, leukocyte, and calcium levels. Therefore, multifaceted planning is needed to reduce its dimensions to improve the prognosis of this group of patients.</p>","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":"23 1","pages":"38-43"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11655010/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142865278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Common Mutations in the Surfactant Protein-C Gene in Iranian Patients with Diffuse Parenchymal Lung Disease. 伊朗弥漫性肺实质疾病患者表面活性蛋白- c基因的常见突变
Q3 Medicine Pub Date : 2024-01-01
Mihan Pourabdollah Toutkaboni, Elham Askari, Jalal Heshmatnia, Mitra Rezaei, Maryam Hasanzad, Atosa Dorudinia, Mehrdad Bakhshayesh Karam, Leila Mohammadi Ziazi, Maryam-Fatemeh Sheikholeslami

Background: Recently, genetic mutations in surfactant protein C (SFTPC) have been linked to diffuse parenchymal lung diseases (DPLD). The present study investigated SFTPC mutations among Iranian patients with DPLD for the first time.

Materials and methods: In this study, we examined 28 patients diagnosed with DPLD. Patients were divided into two groups: 23 cases (82.1%) had interstitial lung disease (ILD), 7 (30.4%) of which were categorized as familial ILD, and 5 cases (17.9%) had pulmonary alveolar proteinosis (PAP). Genetic variations in the SFTPC gene were detected by direct DNA sequencing.

Results: The mean (±SD) age of patients was 21.8 (± 17.1) years and 60.7% of the patients were male. Overall, 11 different mutations were detected in the SFTPC gene. Two novel mutations, c.202-43 G>A and c.416 G>C, were detected among patients. The c.201+49 C>T mutation showed a significant difference with the minor allele frequency (MAF) data. There was no significant difference between the most frequent mutations in Iranian patients and those of the general population in the world. The proximity analysis showed similarity between Iranian patients and patients of the African race. We did not find any correlation between SFTPC mutations and DPLD in the patients.

Conclusion: It seems that the rs2070684 (c.201+49 C>T) mutation could be used as a specific genetic marker for distinguishing the Iranian population from other human races in the world. There was a correlation between some intronic variations and the development of disease. A new missense mutation, c.416 G>C that encodes Arg139Thr, could probably damage the protein structure and/or function and cause the signs and symptoms of DPLD.

背景:最近,表面活性剂蛋白C (SFTPC)基因突变与弥漫性肺实质疾病(DPLD)有关。本研究首次调查了伊朗DPLD患者的SFTPC突变。材料和方法:在本研究中,我们检查了28例诊断为DPLD的患者。患者分为两组:间质性肺病(ILD) 23例(82.1%),家族性ILD 7例(30.4%),肺泡蛋白沉积症(PAP) 5例(17.9%)。通过直接DNA测序检测SFTPC基因的遗传变异。结果:患者平均(±SD)年龄为21.8(±17.1)岁,男性占60.7%。总的来说,在SFTPC基因中检测到11种不同的突变。两个新的突变,c.202-43 G . >A和c.416患者中检测到G>C。C .201+49 C>T突变与次要等位基因频率(MAF)数据差异显著。伊朗患者最常见的突变与世界上一般人群的突变没有显著差异。接近性分析显示伊朗患者和非洲人种患者之间存在相似性。我们没有发现SFTPC突变与患者DPLD之间的任何相关性。结论:rs2070684 (C .201+49 C>T)突变可以作为区分伊朗人与世界其他人种的特异性遗传标记。一些内含子变异与疾病的发展之间存在相关性。一个新的错义突变,c.416编码Arg139Thr的gb> C可能会破坏蛋白质结构和/或功能,从而导致DPLD的症状和体征。
{"title":"Common Mutations in the Surfactant Protein-C Gene in Iranian Patients with Diffuse Parenchymal Lung Disease.","authors":"Mihan Pourabdollah Toutkaboni, Elham Askari, Jalal Heshmatnia, Mitra Rezaei, Maryam Hasanzad, Atosa Dorudinia, Mehrdad Bakhshayesh Karam, Leila Mohammadi Ziazi, Maryam-Fatemeh Sheikholeslami","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Recently, genetic mutations in surfactant protein C (SFTPC) have been linked to diffuse parenchymal lung diseases (DPLD). The present study investigated <i>SFTPC</i> mutations among Iranian patients with DPLD for the first time.</p><p><strong>Materials and methods: </strong>In this study, we examined 28 patients diagnosed with DPLD. Patients were divided into two groups: 23 cases (82.1%) had interstitial lung disease (ILD), 7 (30.4%) of which were categorized as familial ILD, and 5 cases (17.9%) had pulmonary alveolar proteinosis (PAP). Genetic variations in the <i>SFTPC</i> gene were detected by direct DNA sequencing.</p><p><strong>Results: </strong>The mean (±SD) age of patients was 21.8 (± 17.1) years and 60.7% of the patients were male. Overall, 11 different mutations were detected in the <i>SFTPC</i> gene. Two novel mutations, c.202-43 G>A and c.416 G>C, were detected among patients. The c.201+49 C>T mutation showed a significant difference with the minor allele frequency (MAF) data. There was no significant difference between the most frequent mutations in Iranian patients and those of the general population in the world. The proximity analysis showed similarity between Iranian patients and patients of the African race. We did not find any correlation between <i>SFTPC</i> mutations and DPLD in the patients.</p><p><strong>Conclusion: </strong>It seems that the rs2070684 (c.201+49 C>T) mutation could be used as a specific genetic marker for distinguishing the Iranian population from other human races in the world. There was a correlation between some intronic variations and the development of disease. A new missense mutation, c.416 G>C that encodes Arg139Thr, could probably damage the protein structure and/or function and cause the signs and symptoms of DPLD.</p>","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":"23 1","pages":"65-72"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11655001/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142865440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A 67-Year-Old Man with a History of COVID-19 Infection, Cough, and Hemoptysis. 67岁男性,有COVID-19感染、咳嗽和咯血史。
Q3 Medicine Pub Date : 2024-01-01
Niloufar Bineshfar, Alireza Mirahmadi, Afshin Moniri, Seyed Mohammad Poorhosseini, Majid Marjani, Mitra Rezaei
{"title":"A 67-Year-Old Man with a History of COVID-19 Infection, Cough, and Hemoptysis.","authors":"Niloufar Bineshfar, Alireza Mirahmadi, Afshin Moniri, Seyed Mohammad Poorhosseini, Majid Marjani, Mitra Rezaei","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":"23 1","pages":"97-99"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11655006/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142865407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiac Tumor with Dual Component of Myxoma and Angiofibroma Presented with Syncope: An Extremely Rare Case Report. 心脏肿瘤伴黏液瘤和血管纤维瘤双重成分并伴有晕厥:一例极为罕见的病例报告。
Q3 Medicine Pub Date : 2024-01-01
Mohammadhosein Akhlaghpasand, Mehdi Rahab, Setayesh Farahani, Melika Hosseinpour, Sam Zeraatian Nejad

Background: Primary cardiac tumors (PCT), such as myxoma, are rare and predominantly benign. Angiofibroma tumors are an extremely rare subtype of PCT, reported in less than ten cases. In this study, we presented a mixed tumor of myxoma and angiofibroma for the first time in the human heart.

Case presentation: This case report describes a 30-year old man with a positive cerebrovascular accident (CVA) history who presented with syncope, aphasia, and right-side hemiparesis to the emergency department. The imaging assessment, including echocardiography and magnetic resonance imaging, revealed a suspected cardiac tumor in his left atrium extended to the interatrial septum. Therefore, during tumor resection surgery, the mass was removed entirely. Microscopical pathology and desmin immunohistochemical and trichrome staining findings confirmed the angiofibroma diagnosis with myxoma components.

Conclusion: According to our presentation, angiofibroma can be accompanied by myxoma and result in neurological symptoms. The best treatment for this dual component tumor is surgical resection of the tumor and the affected margin.

背景:原发性心脏肿瘤(PCT),如黏液瘤,是罕见的,主要是良性的。血管纤维瘤肿瘤是一种极为罕见的PCT亚型,报道的病例不到10例。在这项研究中,我们首次在人类心脏中报道了黏液瘤和血管纤维瘤的混合肿瘤。病例介绍:本病例报告描述了一名30岁男性,脑血管意外(CVA)病史阳性,以晕厥、失语和右侧偏瘫到急诊室就诊。影像学检查包括超声心动图和磁共振成像,显示疑似心脏肿瘤在左心房延伸至房间隔。因此,在肿瘤切除手术中,肿块被完全切除。显微病理、免疫组化和三色染色结果证实血管纤维瘤的诊断有黏液瘤成分。结论:根据我们的报告,血管纤维瘤可伴有黏液瘤并导致神经系统症状。这种双组份肿瘤的最佳治疗方法是手术切除肿瘤和影响边缘。
{"title":"Cardiac Tumor with Dual Component of Myxoma and Angiofibroma Presented with Syncope: An Extremely Rare Case Report.","authors":"Mohammadhosein Akhlaghpasand, Mehdi Rahab, Setayesh Farahani, Melika Hosseinpour, Sam Zeraatian Nejad","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Primary cardiac tumors (PCT), such as myxoma, are rare and predominantly benign. Angiofibroma tumors are an extremely rare subtype of PCT, reported in less than ten cases. In this study, we presented a mixed tumor of myxoma and angiofibroma for the first time in the human heart.</p><p><strong>Case presentation: </strong>This case report describes a 30-year old man with a positive cerebrovascular accident (CVA) history who presented with syncope, aphasia, and right-side hemiparesis to the emergency department. The imaging assessment, including echocardiography and magnetic resonance imaging, revealed a suspected cardiac tumor in his left atrium extended to the interatrial septum. Therefore, during tumor resection surgery, the mass was removed entirely. Microscopical pathology and desmin immunohistochemical and trichrome staining findings confirmed the angiofibroma diagnosis with myxoma components.</p><p><strong>Conclusion: </strong>According to our presentation, angiofibroma can be accompanied by myxoma and result in neurological symptoms. The best treatment for this dual component tumor is surgical resection of the tumor and the affected margin.</p>","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":"23 1","pages":"90-92"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11655011/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142865435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Association of Smoking and SARS-CoV-2 Infection. 吸烟与SARS-CoV-2感染的关系
Q3 Medicine Pub Date : 2024-01-01
Hooman Sharifi, Atefeh Fakharian, Maryam Sadat Mirenayat, Gordafarid Moradian, Saba Karimzade, Pouria Tuyserkani, Reyhaneh Zahiri, Maryam Akhtari, Mahsa Rekabi, Nafiseh Nikpey, Hamidreza Jamaati

Background: SARS-CoV-2 is a member of the coronavirus family that has caused infections in humans. Iran, as one of the countries in West Asia, is facing a high prevalence of this virus. In this study, we aimed to investigate the association between smoking and COVID-19 outcomes during the pandemic and sociodemographic characteristics.

Materials and methods: This cross-sectional survey was done to assess the frequency of tobacco smoking in COVID-19 patients hospitalized at Masih Daneshvari Hospital, Tehran, Iran. All patients' basic and clinical characteristics, smoking status, and outcomes (ICU admission) were recorded.

Results: A total of 254 participants, of whom 206 (81.10%) provided complete data on variables included in the present analyses. In the present study, 137 (66.5%) of all patients were men and 69 (33.5%) were women. Also, 63 (30.4%) of the study population had a family member with a current disease or history of COVID-19. Fourteen patients (6.79%) were ex-smokers and 34 (16.50%) were current smokers. We found significant relationships between Ex-smoking and ICU admission in COVID-19 patients.

Conclusion: Ex-smoker inpatients with COVID-19 require special attention since they are a vulnerable population with a much higher morbidity rate.

背景:SARS-CoV-2是冠状病毒家族的一员,已在人类中引起感染。伊朗作为西亚国家之一,正面临该病毒的高流行率。在本研究中,我们旨在调查大流行期间吸烟与COVID-19结局和社会人口统计学特征之间的关系。材料与方法:本横断面调查旨在评估伊朗德黑兰Masih Daneshvari医院住院的COVID-19患者吸烟的频率。记录所有患者的基本特征、临床特征、吸烟状况及结果(ICU入院)。结果:共有254名受试者,其中206名(81.10%)提供了本分析中纳入变量的完整数据。在本研究中,男性137例(66.5%),女性69例(33.5%)。此外,63人(30.4%)的研究人群有家庭成员目前患有COVID-19疾病或有COVID-19病史。戒烟者14例(6.79%),现吸烟者34例(16.50%)。我们发现戒烟与COVID-19患者入住ICU有显著关系。结论:住院新冠肺炎戒烟患者是易感人群,发病率较高,需要特别关注。
{"title":"The Association of Smoking and SARS-CoV-2 Infection.","authors":"Hooman Sharifi, Atefeh Fakharian, Maryam Sadat Mirenayat, Gordafarid Moradian, Saba Karimzade, Pouria Tuyserkani, Reyhaneh Zahiri, Maryam Akhtari, Mahsa Rekabi, Nafiseh Nikpey, Hamidreza Jamaati","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>SARS-CoV-2 is a member of the coronavirus family that has caused infections in humans. Iran, as one of the countries in West Asia, is facing a high prevalence of this virus. In this study, we aimed to investigate the association between smoking and COVID-19 outcomes during the pandemic and sociodemographic characteristics.</p><p><strong>Materials and methods: </strong>This cross-sectional survey was done to assess the frequency of tobacco smoking in COVID-19 patients hospitalized at Masih Daneshvari Hospital, Tehran, Iran. All patients' basic and clinical characteristics, smoking status, and outcomes (ICU admission) were recorded.</p><p><strong>Results: </strong>A total of 254 participants, of whom 206 (81.10%) provided complete data on variables included in the present analyses. In the present study, 137 (66.5%) of all patients were men and 69 (33.5%) were women. Also, 63 (30.4%) of the study population had a family member with a current disease or history of COVID-19. Fourteen patients (6.79%) were ex-smokers and 34 (16.50%) were current smokers. We found significant relationships between Ex-smoking and ICU admission in COVID-19 patients.</p><p><strong>Conclusion: </strong>Ex-smoker inpatients with COVID-19 require special attention since they are a vulnerable population with a much higher morbidity rate.</p>","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":"23 1","pages":"83-89"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11655012/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142865388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of STOP-BANG Questionnaire to Predict Postoperative Respiratory Complications after Bariatric Surgery. 使用STOP-BANG问卷预测减肥手术后呼吸系统并发症。
Q3 Medicine Pub Date : 2024-01-01
Parisa Sezari, Farhad Safari, Kamran Mottaghi, Sogol Asgari, Sepideh Parto, Alireza Salimi, Masoud Nashibi

Background: Obstructive sleep apnea (OSA) is the most common sleep-related breathing disorder associated with multisystem organ involvement. The STOP-BANG questionnaire is a short and valid questionnaire used to screen OSA. This study aimed to investigate the ability of the STOP-BANG questionnaire to predict postoperative OSA- related respiratory complications in patients undergoing bariatric surgery.

Materials and methods: In this cross-sectional study, all the eligible patients were evaluated in preoperative visits using a predetermined checklist including demographic and clinical information related to OSA and the STOP-BANG questionnaire. After bariatric surgery, patients were assessed for postoperative OSA-related complications. The receiver operating characteristic (ROC) curve was used to determine the cut-off point of the STOP-BANG checklist score based on the patient's postoperative outcomes.

Results: In total, 115 subjects were included in the study. There were significant associations in terms of gender, age, body mass index (BMI), patient's neck circumference, diabetes, heart diseases, and the mask ventilation grade variables between the two groups of patients with high risk and low risk according to the STOP-BANG questionnaire (P < 0.05 for all comparisons). In addition, ai rway obstruction and hypoxia (mild and moderate) were more prevalent in the high-risk group than in the low-risk one (P < 0.05 for all comparisons). A significant difference was reported with a cut-off score of 2 in the STOP-BANG questionnaire for those with and without airway obstruction. Moreover, the cut-off point of 4 in the STOP-BANG questionnaire was determined as a predictor for both airway obstruction and mild-to-moderate hypoxia.

Conclusion: STOP- BANG scores may be used as a preoperative risk stratification tool to predict the risk of intraoperative adverse events and postoperative complications in bariatric surgery.

背景:阻塞性睡眠呼吸暂停(OSA)是最常见的睡眠相关呼吸障碍,与多系统器官受累有关。STOP-BANG问卷是一份用于筛查OSA的简短而有效的问卷。本研究旨在探讨STOP-BANG问卷对减肥手术患者术后OSA相关呼吸系统并发症的预测能力。材料和方法:在这项横断面研究中,所有符合条件的患者在术前访问时使用预先确定的检查表进行评估,包括与OSA相关的人口学和临床信息以及STOP-BANG问卷。减肥手术后,评估患者术后osa相关并发症。采用受试者工作特征(ROC)曲线根据患者术后预后确定STOP-BANG检查表评分的分界点。结果:共纳入115名受试者。根据STOP-BANG问卷,两组高危和低危患者在性别、年龄、体重指数(BMI)、患者颈围、糖尿病、心脏病、口罩通气等级等变量上均存在显著相关性(P < 0.05)。高危组气道梗阻及轻度、中度缺氧发生率高于低危组(P < 0.05)。在有和没有气道阻塞的患者中,STOP-BANG问卷的截止分数为2,有显著差异。此外,STOP-BANG问卷中的分界点4被确定为气道阻塞和轻度至中度缺氧的预测因子。结论:STOP- BANG评分可作为术前风险分层工具,预测减肥手术术中不良事件及术后并发症的发生风险。
{"title":"Use of STOP-BANG Questionnaire to Predict Postoperative Respiratory Complications after Bariatric Surgery.","authors":"Parisa Sezari, Farhad Safari, Kamran Mottaghi, Sogol Asgari, Sepideh Parto, Alireza Salimi, Masoud Nashibi","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Obstructive sleep apnea (OSA) is the most common sleep-related breathing disorder associated with multisystem organ involvement. The STOP-BANG questionnaire is a short and valid questionnaire used to screen OSA. This study aimed to investigate the ability of the STOP-BANG questionnaire to predict postoperative OSA- related respiratory complications in patients undergoing bariatric surgery.</p><p><strong>Materials and methods: </strong>In this cross-sectional study, all the eligible patients were evaluated in preoperative visits using a predetermined checklist including demographic and clinical information related to OSA and the STOP-BANG questionnaire. After bariatric surgery, patients were assessed for postoperative OSA-related complications. The receiver operating characteristic (ROC) curve was used to determine the cut-off point of the STOP-BANG checklist score based on the patient's postoperative outcomes.</p><p><strong>Results: </strong>In total, 115 subjects were included in the study. There were significant associations in terms of gender, age, body mass index (BMI), patient's neck circumference, diabetes, heart diseases, and the mask ventilation grade variables between the two groups of patients with high risk and low risk according to the STOP-BANG questionnaire (P < 0.05 for all comparisons). In addition, ai rway obstruction and hypoxia (mild and moderate) were more prevalent in the high-risk group than in the low-risk one (P < 0.05 for all comparisons). A significant difference was reported with a cut-off score of 2 in the STOP-BANG questionnaire for those with and without airway obstruction. Moreover, the cut-off point of 4 in the STOP-BANG questionnaire was determined as a predictor for both airway obstruction and mild-to-moderate hypoxia.</p><p><strong>Conclusion: </strong>STOP- BANG scores may be used as a preoperative risk stratification tool to predict the risk of intraoperative adverse events and postoperative complications in bariatric surgery.</p>","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":"23 1","pages":"50-57"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11655009/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142865392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and Phylogenetic Analysis of Rhinoviruses in Patients with Acute Respiratory Infections and Community-Acquired Pneumonia in a Referral Hospital, Tehran, Iran. 伊朗德黑兰一家转诊医院急性呼吸道感染和社区获得性肺炎患者鼻病毒的流行和系统发育分析
Q3 Medicine Pub Date : 2024-01-01
Shadi Fazl, Somayeh Hassani, Mahboobe Ramezan Nia, Proshat Sadat Nadji, Makan Sadr, Fahimeh Nemati, Majid Marjani, Seyed Alireza Nadji

Background: Rhinoviruses are known as the leading pathogens of respiratory diseases. Determining the prevalence and phylogeny of rhinoviruses plays a pivotal role in producing vaccines and medications and preventing virus complications. This study investigated the frequency, and genetic variation of rhinoviruses detected in patients referred to Masih Daneshvari Hospital.

Materials and methods: It was a descriptive cross-sectional study. The samples were from all ages whose information was recorded in 2017 according to a clinical diagnosis of acute respiratory infection (ARI) and in 2015 based on a clinical diagnosis of community-acquired pneumonia (CAP) within the HIS system of Masih Daneshvari Hospital. Using a random number table, 202 patients diagnosed with ARI and 51 patients diagnosed with CAP were selected. The real-time PCR method was used for primary screening; nested PCR was performed in the VP2/VP4 gene region for phylogenetic investigations, and MEGA software drew a phylogenetic tree.

Results: The highest level of rhinovirus infection was seen in subjects under 18 years of age, males, and during the spring season. In this study, the genotypes of HRV-A (including A15, A29, A40, A47, A58, A67, and A80) and HRV-C (including C39 and C44) and two samples of enterovirus D68 were found.

Conclusion: Like other studies conducted in Asia, the most detected genotypes were HRV-A and HRV-C. Conducting further studies with a larger sample size and in different geographical regions of Iran will provide us with more comprehensive information about the frequency of rhinoviruses and common genotypes.

背景:鼻病毒被认为是呼吸道疾病的主要病原体。确定鼻病毒的流行和系统发育在生产疫苗和药物以及预防病毒并发症方面起着关键作用。本研究调查了在Masih Daneshvari医院就诊的患者中检测到的鼻病毒的频率和遗传变异。材料与方法:采用描述性横断面研究。这些样本来自所有年龄段,根据2017年急性呼吸道感染(ARI)的临床诊断和2015年Masih Daneshvari医院HIS系统内社区获得性肺炎(CAP)的临床诊断记录了他们的信息。采用随机数字表法,选取202例诊断为ARI的患者和51例诊断为CAP的患者。采用实时荧光定量PCR法进行初筛;采用巢式PCR对VP2/VP4基因区进行系统发育研究,并用MEGA软件绘制系统发育树。结果:鼻病毒感染率最高的人群为18岁以下的男性和春季。本研究发现HRV-A(包括A15、A29、A40、A47、A58、A67和A80)和HRV-C(包括C39和C44)以及2份肠道病毒D68样本的基因型。结论:与在亚洲进行的其他研究一样,检测到最多的基因型是HRV-A和HRV-C。在伊朗不同地理区域开展更大样本量的进一步研究,将为我们提供有关鼻病毒频率和常见基因型的更全面信息。
{"title":"Prevalence and Phylogenetic Analysis of Rhinoviruses in Patients with Acute Respiratory Infections and Community-Acquired Pneumonia in a Referral Hospital, Tehran, Iran.","authors":"Shadi Fazl, Somayeh Hassani, Mahboobe Ramezan Nia, Proshat Sadat Nadji, Makan Sadr, Fahimeh Nemati, Majid Marjani, Seyed Alireza Nadji","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Rhinoviruses are known as the leading pathogens of respiratory diseases. Determining the prevalence and phylogeny of rhinoviruses plays a pivotal role in producing vaccines and medications and preventing virus complications. This study investigated the frequency, and genetic variation of rhinoviruses detected in patients referred to Masih Daneshvari Hospital.</p><p><strong>Materials and methods: </strong>It was a descriptive cross-sectional study. The samples were from all ages whose information was recorded in 2017 according to a clinical diagnosis of acute respiratory infection (ARI) and in 2015 based on a clinical diagnosis of community-acquired pneumonia (CAP) within the HIS system of Masih Daneshvari Hospital. Using a random number table, 202 patients diagnosed with ARI and 51 patients diagnosed with CAP were selected. The real-time PCR method was used for primary screening; nested PCR was performed in the VP2/VP4 gene region for phylogenetic investigations, and MEGA software drew a phylogenetic tree.</p><p><strong>Results: </strong>The highest level of rhinovirus infection was seen in subjects under 18 years of age, males, and during the spring season. In this study, the genotypes of HRV-A (including A15, A29, A40, A47, A58, A67, and A80) and HRV-C (including C39 and C44) and two samples of enterovirus D68 were found.</p><p><strong>Conclusion: </strong>Like other studies conducted in Asia, the most detected genotypes were HRV-A and HRV-C. Conducting further studies with a larger sample size and in different geographical regions of Iran will provide us with more comprehensive information about the frequency of rhinoviruses and common genotypes.</p>","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":"23 1","pages":"30-37"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11655008/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142865419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
On the Significance of Interdisciplinary Studies of Hikmah and Medicine. 论希克玛与医学跨学科研究的意义。
Q3 Medicine Pub Date : 2024-01-01
Hamed Arezaei
{"title":"On the Significance of Interdisciplinary Studies of Hikmah and Medicine.","authors":"Hamed Arezaei","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":"23 1","pages":"1-2"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11655013/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142865283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationships between Fetal and Neonatal Outcomes and Spectrum of COVID-19 Disease in Pregnant Women. 胎儿和新生儿结局与孕妇COVID-19疾病谱的关系
Q3 Medicine Pub Date : 2024-01-01
Parisa Samadi, Zahra Alipour, Maryam Ghaedrahmati, Mostafa Vahedian

Background: Due to the high prevalence of COVID-19 and the prevention and control of adverse fetal and neonatal outcomes in pregnant women, including vertical transmission, this study was performed to describe the fetal and neonatal outcomes of pregnancy with a spectrum of COVID-19 disease during pregnancy in Iran.

Materials and methods: In this cross-sectional study, we analyzed the medical records of 258 pregnant women admitted to the Forghani Hospital, Qom, Iran, from 18 February 2020, to May 10, 2021. PCR-RT or respiratory compromise in the presence of marked radiographic changes of COVID-19 in the lungs, or both COVID-19 disease confirmed COVID-19 disease. Then, we collected the disease spectrum of COVID-19 and fetal and neonatal outcomes from patient records.

Results: The findings of our study showed that out of 258 pregnant women who were hospitalized due to COVID-19, 79.8% had mild to moderate disease, 16.7% had severe COVID-19, and 3.5% were in the critical stage. After adjusting for the confounding variables, the severity of the disease was significantly associated with adverse fetal and neonatal outcomes such as fetal distress, Intra Uterine Growth Restriction (IUGR), preterm delivery, and Low Birth Weight (LBW), and low first minute Apgar score. However, the severity of COVID-19 was not a predictor of spontaneous preterm delivery, admission to NICU, low Apgar scores at 5 minutes, vertical transmission, stillbirth, and neonatal death.

Conclusion: Neonates of mothers with the severe and critical stage of COVID-19 are exposed to higher potential risks such as fetal distress, IUGR, preterm delivery, LBW, and low Apgar scores at 1 minute than women with mild to moderate disease.

背景:由于COVID-19的高流行率和对孕妇不良胎儿和新生儿结局(包括垂直传播)的预防和控制,本研究旨在描述伊朗妊娠期间具有COVID-19疾病谱的妊娠胎儿和新生儿结局。材料和方法:在这项横断面研究中,我们分析了2020年2月18日至2021年5月10日在伊朗库姆Forghani医院住院的258名孕妇的医疗记录。PCR-RT或肺部有明显的COVID-19影像学改变,或同时有COVID-19疾病确诊的COVID-19疾病。然后,我们从患者记录中收集COVID-19疾病谱以及胎儿和新生儿结局。结果:我们的研究结果显示,258例因新冠肺炎住院的孕妇中,轻至中度疾病占79.8%,重症占16.7%,危重期占3.5%。在调整混杂变量后,疾病的严重程度与胎儿和新生儿的不良结局(如胎儿窘迫、子宫内生长受限(IUGR)、早产、低出生体重(LBW)和低第一分钟Apgar评分)显著相关。然而,COVID-19的严重程度并不是自发性早产、入住NICU、5分钟时Apgar评分低、垂直传播、死产和新生儿死亡的预测因子。结论:COVID-19重症危重期母亲的新生儿比轻中度疾病母亲面临更高的胎儿窘迫、IUGR、早产、LBW、1分钟低Apgar评分等潜在风险。
{"title":"Relationships between Fetal and Neonatal Outcomes and Spectrum of COVID-19 Disease in Pregnant Women.","authors":"Parisa Samadi, Zahra Alipour, Maryam Ghaedrahmati, Mostafa Vahedian","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Due to the high prevalence of COVID-19 and the prevention and control of adverse fetal and neonatal outcomes in pregnant women, including vertical transmission, this study was performed to describe the fetal and neonatal outcomes of pregnancy with a spectrum of COVID-19 disease during pregnancy in Iran.</p><p><strong>Materials and methods: </strong>In this cross-sectional study, we analyzed the medical records of 258 pregnant women admitted to the Forghani Hospital, Qom, Iran, from 18 February 2020, to May 10, 2021. PCR-RT or respiratory compromise in the presence of marked radiographic changes of COVID-19 in the lungs, or both COVID-19 disease confirmed COVID-19 disease. Then, we collected the disease spectrum of COVID-19 and fetal and neonatal outcomes from patient records.</p><p><strong>Results: </strong>The findings of our study showed that out of 258 pregnant women who were hospitalized due to COVID-19, 79.8% had mild to moderate disease, 16.7% had severe COVID-19, and 3.5% were in the critical stage. After adjusting for the confounding variables, the severity of the disease was significantly associated with adverse fetal and neonatal outcomes such as fetal distress, Intra Uterine Growth Restriction (IUGR), preterm delivery, and Low Birth Weight (LBW), and low first minute Apgar score. However, the severity of COVID-19 was not a predictor of spontaneous preterm delivery, admission to NICU, low Apgar scores at 5 minutes, vertical transmission, stillbirth, and neonatal death.</p><p><strong>Conclusion: </strong>Neonates of mothers with the severe and critical stage of COVID-19 are exposed to higher potential risks such as fetal distress, IUGR, preterm delivery, LBW, and low Apgar scores at 1 minute than women with mild to moderate disease.</p>","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":"23 1","pages":"73-82"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11655002/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142865422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship between Underlying Diseases with Morbidity and Mortality in Patients with COVID-19. COVID-19 患者的基础疾病与发病率和死亡率之间的关系。
Q3 Medicine Pub Date : 2023-04-01
Navid Shafigh, Morteza Hasheminik, Batoul Khoundabi, Hamidreza Jamaati, Payam Tabarsi, Majid Marjani, Elnaz Shafigh, Majid Malekmohammad, Navid Nooraei, Seyed Mohammad Reza Hashemian

Background: This study aims to investigate the clinical and demographic features of underlying medical conditions and the potential relationship between underlying diseases and the increased rate of morbidity and mortality due to COVID-19.

Materials and methods: This study was conducted on 350 COVID-19 patients hospitalized at the Masih Daneshvari Hospital from February-July 2021. All participants had confirmed COVID-19 diagnosis based on symptoms and/or positive PCR test or chest X-ray results. Data was collected from medical records on demographics, disease severity, symptoms, underlying conditions like diabetes, hypertension, coronary heart disease, obesity, renal disease/transplantation, and outcomes like hospital stay, ICU admission, and mortality. Relationships between age, underlying diseases, and mortality were analyzed using chi-square and Fisher's exact tests."

Results: A total of 350 patients diagnosed with COVID-19 were included in the study, with an average estimated age of (60.8±15.4). The age group of 56 and above had the highest morbidity rate, which accounted for 50% of the total participants. Among the COVID-19 patients, diabetes was the most common underlying medical condition, accounting for 31.4% of the cases. High blood pressure was present in 27.1% of the patients, and 17.1% of the total participants had coronary heart disease (CHD). Additionally, 10.9% of the participants were overweight, and 30 of them had previously experienced kidney failure or transplantation. Moreover, the study found that 40% of patients with diabetes died, while the mortality rate was 38.3% in patients with CHD and 47.4% in overweight participants. High blood pressure patients had a mortality rate of 43.2%, and patients with renal failure or kidney transplantation had a significantly increased risk of mortality at 83.3%. The research also revealed a significant and direct relationship between mortality rate, age group, and underlying disease among the patients (P<0.05).

Conclusion: The findings of the present study hold significant implications for preventive interventions and policy adoption, particularly in relation to the use of calendar age as the key criterion for risk evaluation. These results underscore the need for a more precise and focused approach to prioritizing patients with identified risk factors.

研究背景本研究旨在调查基础疾病的临床和人口特征,以及基础疾病与 COVID-19 导致的发病率和死亡率增加之间的潜在关系:研究对象为 2021 年 2 月至 7 月期间在马西赫-达内什瓦里医院住院的 350 名 COVID-19 患者。所有参与者均根据症状和/或阳性 PCR 检测或胸部 X 光结果确诊为 COVID-19。我们从病历中收集了有关人口统计学、疾病严重程度、症状、基础疾病(如糖尿病、高血压、冠心病、肥胖症、肾脏疾病/移植)以及住院时间、入住重症监护室和死亡率等结果的数据。采用卡方检验(chi-square)和费雪精确检验(Fisher's exact)分析了年龄、基础疾病和死亡率之间的关系:研究共纳入350名确诊为COVID-19的患者,平均年龄为(60.8±15.4)岁。56岁及以上年龄组发病率最高,占总人数的50%。在 COVID-19 患者中,糖尿病是最常见的基础疾病,占 31.4%。27.1%的患者患有高血压,17.1%的参与者患有冠心病(CHD)。此外,10.9%的参与者超重,其中30人曾经历过肾衰竭或肾移植。研究还发现,40%的糖尿病患者死亡,而冠心病患者的死亡率为 38.3%,超重患者的死亡率为 47.4%。高血压患者的死亡率为 43.2%,肾功能衰竭或肾移植患者的死亡风险显著增加,达到 83.3%。研究还显示,死亡率、年龄组和患者的基础疾病之间存在明显的直接关系:本研究的结果对预防性干预措施和政策的采用具有重要意义,特别是在使用日历年龄作为风险评估的关键标准方面。这些结果突出表明,有必要采取更精确、更有针对性的方法,对具有已识别风险因素的患者进行优先排序。
{"title":"Relationship between Underlying Diseases with Morbidity and Mortality in Patients with COVID-19.","authors":"Navid Shafigh, Morteza Hasheminik, Batoul Khoundabi, Hamidreza Jamaati, Payam Tabarsi, Majid Marjani, Elnaz Shafigh, Majid Malekmohammad, Navid Nooraei, Seyed Mohammad Reza Hashemian","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>This study aims to investigate the clinical and demographic features of underlying medical conditions and the potential relationship between underlying diseases and the increased rate of morbidity and mortality due to COVID-19.</p><p><strong>Materials and methods: </strong>This study was conducted on 350 COVID-19 patients hospitalized at the Masih Daneshvari Hospital from February-July 2021. All participants had confirmed COVID-19 diagnosis based on symptoms and/or positive PCR test or chest X-ray results. Data was collected from medical records on demographics, disease severity, symptoms, underlying conditions like diabetes, hypertension, coronary heart disease, obesity, renal disease/transplantation, and outcomes like hospital stay, ICU admission, and mortality. Relationships between age, underlying diseases, and mortality were analyzed using chi-square and Fisher's exact tests.\"</p><p><strong>Results: </strong>A total of 350 patients diagnosed with COVID-19 were included in the study, with an average estimated age of (60.8±15.4). The age group of 56 and above had the highest morbidity rate, which accounted for 50% of the total participants. Among the COVID-19 patients, diabetes was the most common underlying medical condition, accounting for 31.4% of the cases. High blood pressure was present in 27.1% of the patients, and 17.1% of the total participants had coronary heart disease (CHD). Additionally, 10.9% of the participants were overweight, and 30 of them had previously experienced kidney failure or transplantation. Moreover, the study found that 40% of patients with diabetes died, while the mortality rate was 38.3% in patients with CHD and 47.4% in overweight participants. High blood pressure patients had a mortality rate of 43.2%, and patients with renal failure or kidney transplantation had a significantly increased risk of mortality at 83.3%. The research also revealed a significant and direct relationship between mortality rate, age group, and underlying disease among the patients (P<0.05).</p><p><strong>Conclusion: </strong>The findings of the present study hold significant implications for preventive interventions and policy adoption, particularly in relation to the use of calendar age as the key criterion for risk evaluation. These results underscore the need for a more precise and focused approach to prioritizing patients with identified risk factors.</p>","PeriodicalId":22247,"journal":{"name":"Tanaffos","volume":"22 4","pages":"433-439"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11338504/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142037050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Tanaffos
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1